levonorgestrel has been researched along with Heavy Menstrual Bleeding in 346 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (8.38) | 18.2507 |
| 2000's | 127 (36.71) | 29.6817 |
| 2010's | 123 (35.55) | 24.3611 |
| 2020's | 67 (19.36) | 2.80 |
| Authors | Studies |
|---|---|
| Bahamondes, L; Castro, S; Furlani, RM; Garcia, E; Machado, HC; Monteiro, I | 1 |
| Dawoodbhoy, FM; El-Ghrably, S; Laughton, M; Mahmud, S; Patel, NC | 1 |
| Fu, X; Gong, H; Lan, R; Wang, S; Yang, H | 1 |
| Holopainen, E; Luiro, K | 1 |
| Huguelet, PS; Laurin, JL; Moyer, G; Thornhill, D | 1 |
| Acharya, SS; Appelbaum, H; Juhel, HS | 1 |
| Marquez, CM; Sadowski, EA; Schrager, S; Yogendran, L | 1 |
| Alabaster, A; Anthony, MS; Armstrong, MA; Asiimwe, A; Chillemi, G; Chiu, VY; Fassett, MJ; Gatz, J; Getahun, D; Hunter, S; Ichikawa, LE; Im, TM; Merchant, M; Peipert, JF; Pisa, F; Postlethwaite, D; Raine-Bennett, T; Reed, SD; Ritchey, ME; Saltus, CW; Schoendorf, J; Shi, JM; Takhar, HS; Wang, J; Xie, F; Zhou, X | 1 |
| Adeyemi-Fowode, OA; Baldwin, MK; Borzutzky, C; Dersch, CM; Durazo-Arvizu, RA; Haley, K; Khalighi, M; Kouides, PA; Weyand, AC; Wheeler, AP | 1 |
| Dincgez, B; Ketenci Gencer, F; Yuksel, S | 1 |
| Akira, S; Harada, T; Hirano, K; Kitawaki, J; Maeda, N; Momoeda, M; Murakami, T; Ota, I; Sunaya, T | 1 |
| Lely, AT; Punt, MC; Schutgens, REG; van Dijk, WEM; van Galen, KPM; van Leeuwen, J | 1 |
| Akira, S; Harada, T; Kitawaki, J; Maeda, N; Momoeda, M; Ota, I; Takahashi, N; Yoshihara, K | 1 |
| Beelen, P; Bongers, MY; Bosmans, JE; Clark, TJ; Duijnhoven, RG; Geomini, PMAJ; Herman, MC; Leemans, JC; Mol, BWJ; Oderkerk, TJ; Pannekoek, JN | 1 |
| Baracat, EC; Ferreira-Filho, ES; Magalhaes, J; Soares-Junior, JM | 1 |
| Christian-Rancy, M; Haamid, FW; Kendel, NE; O'Brien, SH; Rosenbaum, LE; Stanek, JR; Zia, A | 1 |
| Akira, S; Harada, T; Hirano, K; Kitawaki, J; Maeda, N; Momoeda, M; Ota, I; Sunaya, T; Umeyama, M | 1 |
| Akaeda, S; Fukui, Y; Hiraoka, T; Hirata, T; Hirota, Y; Iida, R; Ishizawa, C; Kaku, T; Matsuo, M; Omura, E; Osuga, Y | 1 |
| Jensen, JT; Kroll, R; Lukkari-Lax, E; Schulze, A; Serrani, M; Wahdan, Y | 1 |
| Bertelsen, PK; Heinemeier, IIK; Kragsig Thomsen, T; Messerschmidt, L; Rudnicki, M | 1 |
| Alabaster, A; Anthony, MS; Armstrong, MA; Asiimwe, A; Chillemi, G; Chiu, VY; Fassett, MJ; Gatz, J; Getahun, D; Hunter, S; Ichikawa, L; Im, TM; Merchant, M; Peipert, JF; Pisa, F; Postlethwaite, D; Raine-Bennett, T; Reed, SD; Ritchey, ME; Rothman, KJ; Saltus, CW; Schoendorf, J; Shi, JM; Takhar, HS; Wahdan, Y; Wang, J; Xie, F; Zhou, X | 1 |
| Daniels, J; Dutton, B; Gupta, J; Hilken, N; Kai, J; Vinogradova, Y | 2 |
| Chen, CH; Chen, CM; Jui-Shan Lin, S; Su, YC; Tsai, YN; Tseng, YH | 1 |
| Romaniuk, B | 1 |
| Aksoy, L; Gezer, Ş; Köle, E | 1 |
| Andeyro-García, M; Calaf-Alsina, J; Perelló-Capo, J; Rius-Tarruella, J | 1 |
| Bongers, MY; Koolman, X; Mol, BW; Portrait, FRM; van der Hijden, EJE; van Wezep, TC; Vink, MDH | 1 |
| Beshear, D; Lebduska, E; Spataro, BM | 1 |
| Buhur, A; Ünal, Ö | 1 |
| Huguelet, PS; Moyer, G; Wilde, M | 1 |
| Lindblad, AJ; Potter, J | 1 |
| Liu, CH; Wang, PH; Yang, ST | 1 |
| Dutton, B; Kai, J | 1 |
| Barnhart, KT; Creinin, MD; Eisenberg, D; Gawron, LM; Jensen, JT; Mabey, RG | 1 |
| Araújo, MP; Bella, ZIKJ; Depes, DB; Lopes, RGC; Martins, JA; Mata, MVMD; Pereira, AMG | 1 |
| Anthony, MS; Armstrong, MA; Chiu, VY; Fassett, MJ; Gatz, J; Getahun, D; Im, TM; Peipert, JF; Pisa, F; Postlethwaite, D; Raine-Bennett, T; Reed, SD; Ritchey, ME; Rothman, KJ; Schoendorf, J; Shi, JM; Takhar, HS; Wahdan, Y; Wang, J; Xie, F | 1 |
| Clark, MA; Matteson, KA; Raker, CA; Valcin, J | 1 |
| La Marca, A; Selmi, C | 1 |
| Chen, BA; Creinin, MD; Eisenberg, DL; Olariu, AI; Schreiber, CA; Turok, DK | 1 |
| Dietrich, JE; Hernandez, AMC | 1 |
| Alexander Gerds, T; Kuhr Skals, R; Lidegaard, O; Meaidi, A; Torp-Pedersen, C | 1 |
| Bergeron, C; Boutin, A; Laberge, PY; Lemyre, M; Maheux-Lacroix, S; Thériault, MA; Valcourt, F | 1 |
| Parks, MA; Temkit, M; Zwayne, N | 1 |
| Baêta, T; Campos, RR; Rezende, SM; Rocha, ALL; Silva-Filho, A | 1 |
| Kim, DE; Kim, HY; Lee, KH; Lee, S; Lee, SY; Park, DB; Song, SY; Yang, JB; Yoo, HJ | 1 |
| Bofill Rodriguez, M; Jordan, V; Lethaby, A | 1 |
| Bayik, RN; Dolapçioğlu, K; Güngören, A; Şahin, EA; Şahin, H; Sezgin, B; Ün, B | 1 |
| Darre Haahr, P; Grunnet, I; Nielsen, NB; Rudnicki, M | 1 |
| Bongers, MY; Bui, BN; Bullens, LM; Delvaux, EJLG; Geomini, PMAJ; Tibosch, RMG; van der Heijden, PAHH; Veersema, S | 1 |
| Beelen, P; Berger, MY; Bongers, MY; Bossuyt, PM; Coppus, SF; Dekker, JH; Duijnhoven, RG; Eising, HP; Geomini, PMAJ; Herman, MC; Klinkert, ER; Mak, N; Massop-Helmink, DS; Mol, BWJ; Nieboer, TE; Schutte, JM; Smeets, NAC; Timmermans, A; van Baal, M; van den Brink, MJ; van der Steeg, JW; van der Voet, LF; van Meurs, HS; Veersema, S | 1 |
| Guthmann, R; Halajian, E; Lale, A; Nashelsky, J | 1 |
| Bahamondes, L; Brull, EP; Fernandes, A; Juliato, CRT; Monteiro, I | 1 |
| Ainsworth, AJ; Cope, AG; Stewart, EA | 1 |
| Sun, F; Xu, H; Yang, Y; You, M; Yu, Y; Zhang, Y | 1 |
| Samuelson Bannow, B | 1 |
| Beelen, P; Bongers, MY; Duijnhoven, RG; Geomini, PM; Herman, MC; van den Brink, MJ; van der Velde, MGAM | 1 |
| Adeyemi-Fowode, O; Borzutzky, C; Haley, KM; Kouides, P; O'Flynn O'Brien, KL; Wheeler, AP | 1 |
| Beelen, P; Bongers, MY; Duijnhoven, RG; Geomini, PM; Herman, MC; van den Brink, MJ | 1 |
| Bellati, F; Caserta, D; Ciancia, M; Colombrino, C; Costanzi, F; Cozza, G; De Marco, MP; Frega, A; Ruscito, I; Torcia, F | 1 |
| Caetano, C; da Silva Filho, AL; Grandi, G; Lahav, A; Lamaita, RM | 1 |
| Bongers, MY; Geomini, PMAJ; Herman, MC; Oderkerk, TJ; van de Kar, MMA; van der Zanden, CHM | 1 |
| Beelen, P; Berger, MY; Bongers, MY; Dekker, JH; Geomini, PM; Herman, MC; van den Brink, MJ; Vermeulen, KM | 1 |
| Maheux-Lacroix, S | 1 |
| Ashworth, G; Bateson, D; Britt, H; Harrison, C; McGeechan, K | 1 |
| Brown, E; Loeven, M | 1 |
| Beelen, P; Bongers, MY; Dekker, JH; Lukens, MV; Meijer, K; van Borselen, JW; van den Brink, MJ; Wiewel-Verschueren, S | 1 |
| Bianchi, P; Caserta, D; Cozza, G; Frega, A; Giovanale, V; Guarino, A; Marziani, R; Pinto, A | 1 |
| Berger, MY; Dekker, JH; Groenhof, F; Kollen, BJ; Lisman-van Leeuwen, Y; Saaltink, AL; van den Brink, MJ | 1 |
| Clancy, AA; Gerridzen, R; Pascali, D | 1 |
| Adigüzel, C; Aka Satar, D; Arlier, S; Eskimez, E; Kaya, F; Nazik, H; Seyfettinoğlu, S | 1 |
| Ellis, V; Louie, M; Moulder, JK; Schiff, LD; Siedhoff, MT; Spencer, JC; Toubia, T; Wheeler, SB | 1 |
| Ellis, V; Louie, M; Moulder, JK; Schiff, LD; Siedhoff, MT; Spencer, J; Toubia, T; Wheeler, S | 1 |
| AlSharari, SD; Ashraf, MN; Habib-Ur-Rehman, A; Murtaza, G; Shehzad, Z | 1 |
| Czuczwar, P; Paszkowski, T; Szkodziak, F; Szkodziak, PR; Woźniak, S | 1 |
| Cetin, O; Cim, N; Karaman, E; Sayan, S; Soysal, S; Tolunay, HE; Yildizhan, B; Yildizhan, R | 1 |
| Adams, W; Arshanapalli, A; Ethington, E; Graziano, S; Jiang, A; Lullo, JJ; Reserva, J; Tung, R | 1 |
| Burke, CB; McCarthy, CM | 1 |
| Batista Cândido, E; Cristina França Ferreira, M; Lopes da Silva-Filho, A; Lunardi Rocha, AL; Mara Lamaita, R; Mendonça Carneiro, M | 1 |
| Beelen, P; Bongers, MY; Claassen, NJJ; Geomini, PM; Herman, MC; van den Brink, MJ; van den Wijngaard, L; van der Steeg, JW; van Wely, M | 1 |
| Amat, L; Bulach, A; Leclercq, M; Mesrine, S; Scheffler, F; Scheffler, M; Sperandeo, D | 1 |
| King, CP; Kives, S | 1 |
| Elshamy, E; Marawan, H; Rezk, M; Shaheen, AE; Shawky, M | 1 |
| Bofill Rodriguez, M; Brown, J; Lethaby, A; Weterings, MA; Wise, MR | 1 |
| Jiang, X; Xu, X; Yang, H; Yao, Z | 1 |
| Geraldes, F; Silva, CD; Silva, IS | 1 |
| Kaunitz, AM | 2 |
| James, P; Jamieson, MA; Rimmer, E | 1 |
| Filonenko, A; Gidwani, R; Glickman, ME; Hoaglin, DC; Wasiak, R | 1 |
| Baldwin, MK; Jensen, JT | 1 |
| Aalto, AM; Grénman, S; Halmesmäki, K; Heliövaara-Peippo, S; Hurskainen, R; Jokela, M; Kivelä, A; Paavonen, J; Teperi, J; Tomás, E; Tuppurainen, M | 1 |
| Cihangir, U; Ebru, A; Levent, Y; Murat, E | 1 |
| Celimli, FH; Mun, S; Taner, CE; Uysal, A; Uysal, F | 1 |
| Hendriks, E; Prine, L; Rubin, SE | 1 |
| Barton, P; Daniels, J; Frew, E; Gennard, L; Gupta, JK; Kai, J; Middleton, L; Roberts, TE; Sanghera, S | 1 |
| Enache, A; Foidart, JM; Frankenne, F; Gordenne, V; Marinescu, B; Mawet, M; Nizet, D; Nollevaux, F; Parhomenko, V; Segedi, D; Tasev, N; Wijzen, F | 1 |
| Chen, X; Wu, X; Zhu, H | 1 |
| Benzer, N; Celik, C; Kebapcılar, AG; Seçilmiş Kerimoğlu, O; Tazegül Pekin, A; Yılmaz, SA | 1 |
| Pérez-López, FR | 1 |
| Granberg, S | 1 |
| Bastianelli, C; Benagiano, G; Farris, M; Rapiti, S; Vecchio, RB | 1 |
| Fraser, I; Heliövaara-Peippo, S; Hurskainen, R; Paavonen, J; Peuranpää, P | 1 |
| Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T | 2 |
| Altshuler, AL; Hillard, PJ | 1 |
| Cheng, J; Hua, J; Qiu, J; Wang, Q | 1 |
| Albano, A; De Trana, E; Di Cello, A; Gallo, F; La Ferrera, N; Morelli, M; Russo, V; Venturella, R; Zullo, F | 1 |
| Esquivel, P; Stalnaker, M | 1 |
| Amies Oelschlager, AM; Debiec, KE; Mantrala, MD; Micks, EA; Nizamic, T; Prager, SW | 1 |
| Perriera, L; Uhm, S | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Calaf, J; Canals, I; Crespo, C; Cristóbal, I; Espinós, B; Lete, I | 1 |
| Bitzer, J; Calaf-Alsina, J; Fraser, IS; Heikinheimo, O; Nelson, AL | 1 |
| Aprem, AS; Aravindhakshan, R; Bhaskar, S; Chandran, A; Gopimohan, R; Jacob, J | 1 |
| Frew, E; Gupta, JK; Kai, J; Roberts, TE; Sanghera, S | 1 |
| Hussain, M; Lethaby, A; Rees, MC; Rishworth, JR | 1 |
| Baktiroglu, M; Dogan, Y; Kahramanoglu, I; Karateke, A; Senol, T; Suer, N | 1 |
| Farrukh, JB; McKee, N; Towriss, K | 1 |
| Jun, HS; Kim, MK; Kim, ML; Park, DS; Seong, SJ; Song, T; Yun, BS | 1 |
| Leake, R; Stewart, CJ | 1 |
| Barton, P; Daniels, JP; Gray, R; Gupta, JK; Kai, J; Middleton, LJ; Pattison, HM; Prileszky, G; Roberts, TE; Sanghera, S | 1 |
| Critchley, HO; Maybin, JA | 1 |
| Arbat, A; Canals, I; Cristobal, I; Lete, LI; Perulero, N; Viuda, E | 1 |
| Evliyaoglu, O; Haberal, A; Kayikcioglu, F; Kiseli, M | 1 |
| Adeyemi-Fowode, OA; Dietrich, JE; Santos, XM; Srivaths, L | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Chang, XY; Dai, Y; Jia, SZ; Lang, JH; Leng, JH; Li, L; Li, T; Li, XY; Liu, ZZ; Shi, JH; Xu, XX; You, SS; Zhang, JJ; Zhang, JR | 1 |
| Madden, T; McNicholas, C; Mejia, M; Peipert, JF | 1 |
| Coomarasamy, C; Ekeroma, AJ; Shaw, V; Vandal, AC | 1 |
| Daniels, J; Gupta, J; Kai, J; Middleton, L; Pattison, H; Tryposkiadis, K | 1 |
| Bach, F; Toozs-Hobson, P | 1 |
| Fraser, I; Heikinheimo, O | 1 |
| Davies, J; Kadir, RA | 1 |
| Brixner, DI; Chang, J; Doyle, JJ; Hagan, M; Hendlish, SK; Horowicz-Mehler, NC; Stern, LS | 1 |
| Scheinfeld, N | 1 |
| Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
| Beta, J; Grzybowski, W; Jakimiuk, AJ | 1 |
| Bermejo, I; Cornellana, MJ; Izaguirre, F; Lete, I; Obispo, C; Orte, T; Rivero, B | 1 |
| Kumar, U; Samuel, MI; Taylor, C; Tenant-Flowers, M | 1 |
| Akça, A; Api, M; Cetin, A; Gorgen, H | 1 |
| Gaetje, R | 1 |
| Caglar, GS; Cengiz, H; Gunes, M; Kayikcioglu, F; Tasci, Y; Yagci, B | 1 |
| Gupta, J; Kai, J; Prileszky, G | 1 |
| Andrade, A; Wildemeersch, D | 2 |
| Derniaux, E; Graesslin, O | 1 |
| Hill, DA | 1 |
| Endrikat, J; Fortier, M; Kunz, M; Lukkari-Lax, E; Schmidt, W; Shapiro, H | 1 |
| Goñi, AZ; Hernández Rivas, FJ; Lacruz, RL; Paricio, JJ | 1 |
| Akinsu, F; Bardakci, H; Doganay, M; Kilic, S; Mollamahutoglu, L; Uzunlar, O; Yuksel, B | 1 |
| Brun, JL; Dallay, D; Quiboeuf, E; Randriambelomanana, J | 1 |
| Grenman, S; Halmesmäki, K; Heliövaara-Peippo, S; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Teperi, J; Tuppurainen, M; Vuorma, S; Yliskoski, M | 1 |
| Cebi, M; Murat Naki, M; Ozcan, N; Tekcan, C | 1 |
| Dueholm, M | 1 |
| Grenman, S; Halmesmäki, K; Heliövaara-Peippo, S; Hurskainen, R; Kivelä, A; Paavonen, J; Teperi, J; Tomas, E; Tuppurainen, M | 1 |
| Araújo, CA; Camargos, AF; de Rezende, CP; de Souza, SS; Pereira, FA; Silva Filho, AL | 1 |
| Maruo, T | 1 |
| Burke, AE; McDonald-Mosley, R | 1 |
| Shimoni, N | 1 |
| Nelson, AL | 1 |
| Aslam, N; Blunt, S; Latthe, P | 1 |
| Curtis, KM; Jamieson, DJ; Marchbanks, PA; Tepper, NK; Whiteman, MK; Zapata, LB | 1 |
| Agostini, A; Bazot, M; Brailly-Tabard, S; Brun, JL; Chabbert-Buffet, N; Cravello, L; De Raucourt, E; Fauconnier, A; Fernandez, H; Gervaise, A; Golfier, F; Gompel, A; Gondry, J; Graesslin, O; Huchon, C; Lucot, JP; Marret, H; Plu-Bureau, G; Roman, H | 1 |
| Chen, SU; Ho, HN; Peng, FS; Wu, MY; Yang, JH; Yang, YS | 1 |
| Abbott, J; Barrington, J; Bhattacharya, S; Bongers, MY; Brun, JL; Busfield, R; Champaneria, R; Clark, TJ; Cooper, J; Cooper, KG; Corson, SL; Daniels, JP; Dickersin, K; Dwyer, N; Gannon, M; Gray, R; Hawe, J; Hilken, NH; Hurskainen, R; Khan, KS; Meyer, WR; Middleton, LJ; O'Connor, H; O'Donovan, P; Pinion, S; Sambrook, AM; Sowter, M; Tam, WH; van Zon-Rabelink, IA; Zupi, E | 1 |
| Arina, R; Bermejo, A; del Carme Cuesta, M; Lete, I; Marín, JM; Martínez, M | 1 |
| Bissonnette, F; Jensen, JT; Kaunitz, AM; Lukkari-Lax, E; Monteiro, I; Muysers, C | 1 |
| Chen, W; Maruo, T; Nakabayashi, K; Ohara, N; Sasaki, H; Xu, Q; Yamada, H; Yoshida, S | 1 |
| Ahuja, SP; Hertweck, SP | 1 |
| Constantine, GD; Fortier, MP; Grubb, GS; Mirkin, S; Reid, RL; Smith, L | 1 |
| Akgul, MA; Akyol, M; Haberal, A; Kaplan, M; Karcaaltincaba, M; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| El-Nashar, SA; Sayed, GH; Shaaban, MM; Zakherah, MS | 1 |
| Chelmow, D | 1 |
| El-Nashar, SA; Sayed, GH; Shaaban, MM; Shabaan, MM; Zakherah, MS | 1 |
| Chi, C; Huq, FY; Kadir, RA | 1 |
| Ayub, R; Jaffery, T; Kamal, M; Naseem, F; Rahim, F; Tariq, N | 1 |
| Endrikat, J; Fortier, M; Lukkari-Lax, E; Muysers, C; Solomayer, E; Vilos, G | 1 |
| Barton, PM; Bhattacharya, S; Champaneria, R; Cooper, KG; Daniels, JP; Middleton, LJ; Roberts, TE; Tsourapas, A | 1 |
| Abbott, J; Barrington, J; Barton, P; Bhattacharya, S; Bongers, MY; Brun, JL; Busfield, R; Champaneria, R; Chien, P; Clark, TJ; Cooper, J; Cooper, KG; Corson, SL; Daniels, JP; Dickersin, K; Dwyer, N; Gannon, M; Gray, R; Hawe, J; Hilken, NH; Hurskainen, R; Khan, KS; Lee, AJ; Meyer, WR; Middleton, LJ; O'Connor, H; O'Donovan, P; Pinion, S; Roberts, T; Sambrook, AM; Tam, WH; Tsourapas, A; van Zon-Rabelink, IA; Zupi, E | 1 |
| Kang, BH; Ko, YB; Lee, KH; Lee, MA; Yang, JB; Yoo, HJ | 1 |
| Grenman, S; Halmesmäki, K; Heliövaara-Peippo, S; Hurskainen, R; Kaaja, R; Kivelä, A; Oksjoki, R; Paavonen, J; Surcel, HM; Teperi, J; Tomas, E; Tuppurainen, M | 1 |
| Chakravarty, PS; Chattopdhyay, B; Goswami, S; Nigam, A | 1 |
| Daniels, JP; Gupta, JK; Kai, J; Pattison, H | 1 |
| Blidaru, I; Boiculese, L; Miron, N; Socolov, D; Socolov, R; Tamba, B | 1 |
| Agarwal, N; Awasthi, D; Kriplani, A; Kulshrestha, V | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O | 1 |
| Grenman, S; Halmesmäki, K; Heliövaara-Peippo, S; Hurskainen, R; Kivelä, A; Leminen, H; Paavonen, J; Teperi, J; Tuppurainen, M | 1 |
| Bouchard, P | 1 |
| Inki, P; Kaunitz, AM | 1 |
| Agius, RC; Baron, YM; Brincat, M; Craus, J | 1 |
| Byrne, P; Ramhendar, T | 1 |
| Bahamondes, L; Bahamondes, MV; de Lima, Y; Monteiro, I; Teich, V | 1 |
| Byrne, P; Vaughan, D | 1 |
| Piancatelli, R; Piccione, E; Pietropolli, A; Ruggeri, V; Sesti, F | 1 |
| Archer, DF | 1 |
| Kelekci, KH; Kelekci, S; Yilmaz, B | 1 |
| Bissonnette, F; DeSanctis, Y; Jensen, J; Kaunitz, AM; Lukkari-Lax, E; Monteiro, I | 1 |
| Burock, K; Fraser, IS; Inki, P; Jensen, J; Lukkari-Lax, E; Mansour, D | 1 |
| Chen, J; Wan, S; Xie, ZW; Xu, WZ; Zhang, YN | 1 |
| Camargos, AF; Carneiro, MM; de Souza, SS; Loures, LF; Pereira, Fde A; Rocha, AP; Silva-Filho, AL; Tavares, RL; Valadares, CN | 1 |
| Daniels, J; Gray, R; Gupta, J; Kai, J; Middleton, L; Pattison, H | 1 |
| Espey, E | 1 |
| Kmietowicz, Z | 1 |
| Asif, S; Hanisch, JU; Inki, P; Kraemer, P; Lee, BS; Ling, X | 1 |
| Fraser, IS; Hickey, M | 2 |
| Schacht, E; Wildemeersch, D; Wildemeersch, P | 1 |
| Farquhar, CM | 1 |
| Ekholm, E; Grenman, S; Hurskainen, R; Inki, P; Kivelä, A; Kujansuu, E; Paavonen, J; Palo, P; Teperi, J; Yliskoski, M | 1 |
| Ikomi, A; Pepra, EF | 1 |
| Adekunle, AO; Arowojolu, AO; Okewole, IA | 1 |
| Georgiou, M; Hyatt, D; Jones, K; Spencer, T; Thomas, H | 1 |
| Hurskainen, R; Paavonen, J; Teperi, J | 1 |
| Nwosu, EC; Sinha, A | 1 |
| Johansson, E; Laoag-Fernandez, JB; Maruo, T; Pakarinen, P; Spitz, IM | 1 |
| Bifulco, G; Cerrota, G; De Simone, R; Di Spiezio Sardo, A; Mercorio, F; Nappi, C; Vanacore, F | 1 |
| Abdel-Fattah, M; Arunkalaivanan, AS; Barrington, JW | 1 |
| Chong, J; Han, LH; Luukkainen, T; Wu, SC; Xiao, B; Zeng, T | 1 |
| Eizenberg, DH | 1 |
| Grenman, S; Halmesmäki, K; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Teperi, J; Tiitinen, A; Yliskoski, M | 1 |
| Aalto, AM; Grenman, S; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Rissanen, P; Teperi, J; Vuorma, S; Yliskoski, M | 3 |
| Levenson, D | 1 |
| Rowe, PJ; Wildemeersch, D | 2 |
| Puzey, M | 1 |
| Ben-Haroush, A; Kaplan, B; Oron, G; Yeshaya, A; Yogev, Y | 1 |
| Soysal, ME; Soysal, S | 1 |
| Hurskainen, R; Paavonen, J | 1 |
| Elo, I; Istre, O; Rauramo, I | 1 |
| Economides, DL; Kadir, RA; Kingman, CE; Lee, CA | 1 |
| Chegini, N; Hardt, N; Rhoton-Vlasak, A; Williams, RS | 1 |
| Lukes, AS; Ortel, TL; Perry, S | 1 |
| Meulendijks, CF; Thijssen, RF; van der Wilt, GJ | 1 |
| Critchley, H; Osei, J | 1 |
| Banu, NS; Manyonda, IT | 1 |
| Reid, PC; Virtanen-Kari, S | 1 |
| Ibraheim, M; Ikomi, A | 1 |
| Chowdary, GV; Murthy, JM; Narayanan, TJ | 1 |
| Al-Azzawi, F; Wahab, M | 1 |
| Dolan, G; Powell, MC; Schaedel, ZE | 1 |
| Cândido dos Reis, FJ; de Sá Rosa e Silva, AC; Ferriani, RA; Manetta, LA; Nogueira, AA; Rosa e Silva, JC | 1 |
| Cooke, I; Lethaby, AE; Rees, M | 2 |
| Clark, TJ; Gupta, JK; Neelakantan, D | 1 |
| Gupta, JK; Sinha, D; Varma, R | 1 |
| Curtis, R; Inki, P | 1 |
| Gunes, M; Haberal, A; Kaplan, M; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Brown, P; Busfield, RA; Farquhar, CM; Johnson, N; Lethaby, A; Sadler, LC; Sowter, MC; Sprecher, M; Yu, Y | 1 |
| MoYuen, P; Sahota, DS; You, JH | 1 |
| Leung, PL; Lok, IH; Rogers, MS; Shan Ng, DP; Tam, WH; Yuen, PM | 1 |
| Gunes, M; Haberal, A; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Hurskainen, R | 1 |
| Brown, PM; Farquhar, CM; Johnson, NP; Lethaby, A; Sadler, LC | 1 |
| Rabinovici, J; Stewart, EA | 1 |
| Chi, C; Kadir, RA | 2 |
| Madelenat, P; Omnes, S; Vacher-Lavenu, MC; Yazbeck, C | 1 |
| Koh, SC; Singh, K | 1 |
| Heikinheimo, O; Lehtovirta, P; Paavonen, J | 1 |
| Cuadrado, MJ; Hunt, BJ; Khamashta, MA; Pisoni, CN | 1 |
| Aldrighi, JM; de Lima, GR; Magalhães, J | 1 |
| Cacciatore, B; Halmesmäki, KH; Hurskainen, RA; Paavonen, JA; Tiitinen, A | 1 |
| Agarwal, N; Kriplani, A; Lal, S; Singh, BM | 1 |
| Grenman, S; Halmesmäki, K; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Teperi, J; Tuppurainen, M; Vuorma, S; Yliskoski, M | 1 |
| Duckitt, K | 1 |
| Doyle, J; Etschmaie, MR; Kaunitz, AM; Stern, L | 1 |
| Milsom, I | 2 |
| Luukkainen, T; Pakarinen, P | 1 |
| Inki, P | 1 |
| Grimes, DA; Lopez, LM; Manion, C; Schulz, KF | 1 |
| Mansour, D | 1 |
| Clegg, JP; Guest, JF; Hurskainen, R | 1 |
| Baird, DT; Critchley, HO; Dada, K; Elton, R; Glasier, AF; Ho, PC; Lakha, F; Van der Spuy, ZM; Williams, AR | 1 |
| Chaplain, J; Mukhopadhyay, S; Shaw, RW; Symonds, IM; Tamizian, O | 1 |
| de Jonge, ET; Molenberghs, G; Ombelet, W; Straetmans, D; Yigit, R | 1 |
| Aalto, AM; Elovainio, M; Grenman, S; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Teperi, J; Vuorma, S; Yliskoski, M | 1 |
| Higgins, M; Kelehan, P; O'Herlihy, C; Rizkalla, HF | 1 |
| Gupta, HP; Singh, U; Sinha, S | 1 |
| Fraser, IS; Kouides, PA; Lukes, AS; Porte, RJ | 1 |
| Ertan, K; Küçük, T | 1 |
| Armstrong, A; Martin-Johnston, MK; Okoji, OY | 1 |
| Lo, SS; Tang, GW | 1 |
| Andersson, K; Odlind, V; Rybo, G | 1 |
| Luukkainen, T; Toivonen, J | 1 |
| Hamerlynck, JV | 1 |
| Amatya, RN; Dunson, TR; Krueger, SL | 1 |
| Barrington, JW; Bowen-Simpkins, P | 1 |
| Cortesi, I; Crosignani, PG; De Giorgi, O; Mosconi, P; Oldani, S; Vercellini, P | 1 |
| Bianchi, S; Dorta, M; Fedele, L; Portuese, A; Raffaelli, R | 1 |
| Cameron, IT; Campbell, S; Church, HJ; Irvine, GA; Kohnen, G; MacLachlan, F; Titterington, M | 1 |
| Duckitt, K; Shaw, RW | 1 |
| Cameron, IT; Campbell-Brown, MB; Heikkilä, A; Irvine, GA; Lumsden, MA; Walker, JJ | 1 |
| Guillebaud, J | 1 |
| Gupta, N; Ikomi, A | 1 |
| Dwarte, D; Fraser, IS; Hickey, M | 2 |
| Delbarge, W; Dhont, M; Schacht, E; Temmerman, M; Thiery, M; Wildemeersch, D | 1 |
| Choy, CC; Paul, AC | 1 |
| Bianchi, S; Fedele, L; Gammaro, L | 1 |
| Fong, YF; Singh, K | 2 |
| Prentice, A | 1 |
| Duffy, S; Hawe, J; Rogerson, L | 1 |
| Cameron, IT; Irvine, GA | 1 |
| Römer, T | 1 |
| Finne, P; Hurskainen, R; Nokelainen, K; Rutanen, E | 1 |
| Crocombe, W; Dassu, D; Duffy, S; Rogerson, L; Stead, M | 1 |
| Hurskainen, R; Paavonen, J; Rutanen, E; Salmi, A; Teperi, J | 1 |
| Iwanicki, M; Starczewski, A | 1 |
| Duffy, S; Kremer, C | 1 |
| Cummins, C; Gold, L; Jordan, R; Phillips, W; Stewart, A | 1 |
| Kunz, J | 1 |
| Cameron, IT | 1 |
| Bongers, MY; Brölmann, HA; Mol, BW | 1 |
| Busfield, R; Farquhar, C; Johnson, N; Lethaby, A; Sadler, L | 1 |
| Istre, O; Trolle, B | 1 |
| Schacht, E; Wildemeersch, D | 2 |
| Johansson, E; Laoag-Fernandez, JB; Maruo, T; Murakoshi, H; Pakarinen, P; Spitz, IM | 1 |
| Luukkainen, T; Pakarinen, P; Toivonen, J | 1 |
| Bratschi, HU | 1 |
| Barrington, JW; Bowen-Simpkins, P; Nagrani, R | 1 |
| Cardamakis, E; Fotopoulos, A; Georgopoulos, A; Lazaris, D; Pappas, AP; Sykiotis, GP; Tzingounis, VA | 1 |
| Bahamondes, L; Diaz, J; Monteiro, I; Perrotti, M; Petta, C | 1 |
| Barry, C; Coyle, C; Henshaw, R; Low, S | 1 |
| Ozer, S; Soysal, M; Soysal, S | 1 |
| Luo, LL; Zhang, JY | 1 |
| Barlow, DH; Rees, MC | 1 |
| Andersch, B; Andersson, K; Milsom, I; Rybo, G | 1 |
| Luukkainen, T | 1 |
| Lähteenmäki, P; Luukkainen, T; Toivonen, J | 1 |
| Andersson, JK; Rybo, G | 1 |
77 review(s) available for levonorgestrel and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review.
Topics: Adult; Cohort Studies; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Young Adult | 2022 |
Abnormal Uterine Bleeding.
Topics: Contraceptives, Oral; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Oral hormonal therapy as treatment option for abnormal uterine bleeding.
Topics: Contraceptives, Oral, Combined; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Progestins; Quality of Life; Uterine Hemorrhage | 2023 |
Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Topics: Adult; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Treatment Outcome; Uterus; Young Adult | 2020 |
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome | 2020 |
What is the best drug treatment for premenopausal women with bleeding irregularities using the levonorgestrel-releasing intrauterine system? A systematic review.
Topics: Contraceptive Agents, Hormonal; Cyclooxygenase Inhibitors; Estradiol; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Naproxen; Premenopause | 2020 |
Which medications work best for menorrhagia?
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Danazol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Menorrhagia; Tranexamic Acid; Young Adult | 2020 |
Current and Future Medical Therapies for Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life | 2020 |
Management of heavy menstrual bleeding on anticoagulation.
Topics: Adult; Anticoagulants; Female; Humans; Levonorgestrel; Menorrhagia; Pyrazoles; Pyridones; Quality of Life; Rivaroxaban; Venous Thromboembolism | 2020 |
The combined use of endometrial ablation or resection and levonorgestrel-releasing intrauterine system in women with heavy menstrual bleeding: A systematic review.
Topics: Combined Modality Therapy; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2021 |
Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.
Topics: Decision Support Techniques; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Models, Theoretical; Treatment Outcome | 2017 |
Combined hormonal contraceptives for heavy menstrual bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Danazol; Drug Therapy, Combination; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Naproxen; Nausea; Placebos; Progestins; Randomized Controlled Trials as Topic | 2019 |
Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.
Topics: Bayes Theorem; Danazol; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Progestins; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Contraception during the perimenopause.
Topics: Contraception; Contraceptive Agents, Female; Contraindications; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Perimenopause; Pregnancy; Pregnancy, Unplanned; United States | 2013 |
Abnormal bleeding in your female patient? Consider a progestin IUD.
Topics: Adult; Diagnosis, Differential; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Treatment Outcome | 2014 |
Menstrual suppression for adolescents.
Topics: Adolescent; Adolescent Health Services; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Pelvic Pain; Quality of Life; Treatment Outcome | 2014 |
Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.
Topics: Contraceptive Agents, Female; Drug Administration Routes; Female; Humans; Levonorgestrel; Menorrhagia; Uterus | 2014 |
Hormonal contraception as treatment for heavy menstrual bleeding: a systematic review.
Topics: Contraceptive Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia | 2014 |
Medical management of heavy menstrual bleeding: a comprehensive review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2015 |
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Randomized Controlled Trials as Topic | 2015 |
Medical management of heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Women's Health | 2016 |
Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
Topics: Adolescent; Adult; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Ontario; Technology Assessment, Biomedical; Young Adult | 2016 |
The current status of hormonal therapies for heavy menstrual bleeding.
Topics: Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins | 2017 |
Heavy menstrual bleeding: An update on management.
Topics: Adult; Contraceptive Agents; Disease Management; Female; Hemostasis; Hormones; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norpregnadienes; Quality of Life; Young Adult | 2017 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
[Dysfunctional uterine bleeding--diagnostics and treatment].
Topics: Adult; Catheter Ablation; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Endometrium; Female; Humans; Intrauterine Devices; Laparoscopy; Laser Therapy; Levonorgestrel; Menorrhagia; Patient Satisfaction; Quality of Life; Women's Health | 2008 |
[Benefits of a levonorgestrel-releasing intrauterine device].
Topics: Endometrium; Female; Humans; Hysterectomy; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Patient Satisfaction | 2009 |
Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Pregnancy; Uterine Perforation | 2010 |
Intrauterine contraceptives: a review of uses, side effects, and candidates.
Topics: Contraception, Postcoital; Delayed-Action Preparations; Endometriosis; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2010 |
Intrauterine device use among women with uterine fibroids: a systematic review.
Topics: Contraceptive Agents, Female; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage; Uterine Neoplasms | 2010 |
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Coagulation Disorders; Contraceptives, Oral, Combined; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvis; Prevalence; Tranexamic Acid; Ultrasonography | 2010 |
Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Length of Stay; Levonorgestrel; Menorrhagia; Patient Satisfaction; Randomized Controlled Trials as Topic; Regression Analysis; Treatment Outcome | 2010 |
Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
Topics: Animals; Extracellular Matrix; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Neovascularization, Pathologic; Progesterone; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms | 2010 |
Overview of bleeding disorders in adolescent females with menorrhagia.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders, Inherited; Contraceptives, Oral; Endometriosis; Female; Hemorrhagic Disorders; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts | 2010 |
The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia.
Topics: Adult; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Ablation Techniques; Female; Health Resources; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2011 |
Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Patient Satisfaction; Postoperative Complications; Quality-Adjusted Life Years; Time; Treatment Outcome | 2011 |
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2012 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Risk Assessment | 2012 |
Vascular dysfunction as a cause of endometrial bleeding.
Topics: Contraceptives, Oral, Synthetic; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Metrorrhagia | 2012 |
Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities.
Topics: Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Diseases; Uterine Neoplasms | 2002 |
Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Polyps; Progesterone Congeners | 2002 |
FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health.
Topics: Administration, Intravaginal; Adult; Contraceptive Agents, Female; Contraindications; Counseling; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menorrhagia; Reproductive Health Services; World Health Organization | 2004 |
Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2004 |
Menorrhagia, mechanisms and targeted therapies.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Receptors, Progesterone; Treatment Outcome | 2005 |
Alternative medical and surgical options to hysterectomy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Endometrium; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Menorrhagia; Myometrium; Quality of Life; Uterine Diseases | 2005 |
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Progesterone | 2005 |
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Topics: Delayed-Action Preparations; Dysmenorrhea; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2006 |
Managing drug-resistant essential menorrhagia without hysterectomy.
Topics: Catheter Ablation; Contraceptive Agents, Female; Cost-Benefit Analysis; Drug Resistance; Endometrium; Evidence-Based Medicine; Female; Gynecologic Surgical Procedures; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Treatment Outcome | 2006 |
New interventional techniques for adenomyosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Danazol; Diagnosis, Differential; Embolization, Therapeutic; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Pregnancy; Uterine Diseases; Uterine Neoplasms | 2006 |
Women and von Willebrand disease: controversies in diagnosis and management.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Contraceptives, Oral, Synthetic; Deamino Arginine Vasopressin; Endometrium; Female; Genital Diseases, Female; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Tranexamic Acid; von Willebrand Diseases | 2006 |
Medical management of perimenopausal menorrhagia: an evidence-based approach.
Topics: Administration, Oral; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Menorrhagia; Perimenopause; Progestins; Randomized Controlled Trials as Topic; Uterus | 2007 |
Treatment of menorrhagia with an LNG-IUS.
Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2007 |
Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy.
Topics: Anticoagulants; Blood Coagulation Disorders, Inherited; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2007 |
Progestin-releasing intrauterine systems and leiomyoma.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2007 |
The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
Topics: Female; Health Care Costs; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Perimenopause; Progestins; Quality of Life; Randomized Controlled Trials as Topic | 2007 |
Long-term use of the levonorgestrel-releasing intrauterine system.
Topics: Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menopause; Menorrhagia; Progestins; Randomized Controlled Trials as Topic; Sterilization, Reproductive | 2007 |
Cochrane systematic reviews of IUD trials: lessons learned.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic | 2007 |
Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2007 |
Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia | 2007 |
A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Danazol; Deamino Arginine Vasopressin; Female; Gonadotropin-Releasing Hormone; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Risk Assessment; Tranexamic Acid | 2008 |
Therapeutic amenorrhea in patients at risk for thrombocytopenia.
Topics: Adult; Comorbidity; Contraceptive Agents, Female; Danazol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cell Transplantation; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Thrombocytopenia | 2008 |
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Pregnancy, Ectopic | 1995 |
[Levonorgestrel capsules: a big leap forward in intrauterine contraception].
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone Congeners | 1996 |
Fortnightly review. Medical management of menorrhagia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 1999 |
Medical management of dysfunctional uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Combined; Danazol; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 1999 |
Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone; Progesterone Congeners | 2000 |
Endometrial ablation: the next generation.
Topics: Catheter Ablation; Catheterization; Cryotherapy; Endometrium; Female; Humans; Hyperthermia, Induced; Laser Therapy; Levonorgestrel; Menorrhagia; Microwaves; Photochemotherapy; Sodium Chloride | 2000 |
The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review.
Topics: Adult; Delayed-Action Preparations; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
[Levonorgestrel releasing intrauterine spiral--contraception and therapeutic indications].
Topics: Adult; Aged; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2001 |
The levonorgestrel intrauterine system: the benefits of reduced bleeding.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation; Uterine Hemorrhage | 2001 |
Therapeutic use of the LNG IUS, and counseling.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contraceptive Agents, Female; Counseling; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Premenstrual Syndrome | 2001 |
Levonorgestrel intra-uterine system for menorrhagia.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Hysteroscopic endometrial resection.
Topics: Endometrium; Female; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged | 2000 |
Levonorgestrel-releasing intrauterine device.
Topics: Contraceptive Agents, Female; Counseling; Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Norgestrel; Ovary | 1991 |
Levonorgestrel-releasing intrauterine device.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norgestrel | 1990 |
77 trial(s) available for levonorgestrel and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
Topics: Contraceptive Agents, Female; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Multicenter Studies as Topic; Pelvic Pain; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
Topics: Cohort Studies; Demography; Dysmenorrhea; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Risk Factors | 2022 |
Vaginal micronized progesterone versus the levonorgestrel-releasing intrauterine system for treatment of non-atypical endometrial hyperplasia: A randomized controlled trial.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone; Prospective Studies; Quality of Life | 2023 |
Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Prospective Studies; Treatment Outcome | 2023 |
A randomized trial comparing the 52-mg levonorgestrel system with combination oral contraceptives for treatment of heavy menstrual bleeding.
Topics: Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2023 |
Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Netherlands; Patient Satisfaction; Quality of Life; Retreatment; Sexual Health; Treatment Outcome | 2021 |
Treatment of women with heavy menstrual bleeding: Results of a prospective cohort study alongside a randomised controlled trial.
Topics: Adult; Contraceptive Agents, Female; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Netherlands | 2021 |
The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.
Topics: Adult; Cost-Benefit Analysis; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Netherlands; Treatment Outcome | 2021 |
Clinical efficacy of levonorgestrel and norethisterone for the treatment of chronic abnormal uterine bleeding.
Topics: Administration, Oral; Adult; Chronic Disease; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Treatment Outcome | 2017 |
Effects of a levonorgestrel intrauterine system versus a copper intrauterine device on menstrual changes and uterine artery Doppler.
Topics: Adult; Contraceptive Agents, Female; Egypt; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ultrasonography, Doppler; Uterine Artery; Young Adult | 2019 |
Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
Topics: Adult; Anxiety; Cost-Benefit Analysis; Depression; Female; Follow-Up Studies; Health Care Costs; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2013 |
Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovary; Prospective Studies; Risk Factors; Time Factors; Turkey; Uterine Artery; Uterus | 2013 |
Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Models, Statistical; Quality of Life; Treatment Outcome | 2014 |
Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.
Topics: Adult; Blood Volume; Contraceptives, Oral, Synthetic; Female; Ferritins; Hemoglobins; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Single-Blind Method | 2014 |
Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding.
Topics: Adult; Anemia; Anxiety; Contraceptive Agents, Female; Depression; Female; Ferritins; Follow-Up Studies; Hemoglobins; Humans; Hysterectomy; Intrauterine Devices, Medicated; Iron; Iron Deficiencies; Levonorgestrel; Linear Models; Menorrhagia; Middle Aged; Quality of Life; Surveys and Questionnaires | 2014 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
A clinical study assessing the efficacy of a new variant of the levonorgestrel intrauterine system for abnormal uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Prospective Studies; Quality of Life; Time Factors | 2015 |
Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Topics: Adult; Amenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Uterine Neoplasms | 2015 |
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Primary Health Care; Quality-Adjusted Life Years; Surveys and Questionnaires; Technology Assessment, Biomedical; Tranexamic Acid; Treatment Outcome | 2015 |
Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study.
Topics: Adult; Anemia; Female; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Reproductive Control Agents; Tranexamic Acid | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.
Topics: Adult; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Treatment Outcome; United Kingdom | 2016 |
Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Turkey | 2009 |
A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Topics: Adult; Canada; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Norethindrone Acetate; Prospective Studies; Severity of Illness Index | 2009 |
The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement.
Topics: Adult; Anticoagulants; Female; Ferritins; Heart Valve Prosthesis; Hematocrit; Hemoglobins; Humans; International Normalized Ratio; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2009 |
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
Topics: Abdominal Pain; Adult; Back Pain; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Statistics, Nonparametric; Surveys and Questionnaires | 2009 |
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial.
Topics: Adult; Contraceptive Agents, Female; Female; Finland; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Urinary Tract Infections; Urination Disorders | 2010 |
A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding.
Topics: Adult; Analysis of Variance; Catheterization; Endometrial Ablation Techniques; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Patient Satisfaction; Patient Selection; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2010 |
Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Middle Aged | 2010 |
Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis.
Topics: Adult; Endometriosis; Female; Fertility Agents, Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Treatment Outcome; Uterine Diseases | 2011 |
A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Treatment Failure; Treatment Outcome | 2011 |
Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Kaplan-Meier Estimate; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Young Adult | 2011 |
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: a 10-year follow-up of a randomised trial.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Hysterectomy; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Progestins; Risk Factors; Tumor Necrosis Factor-alpha | 2011 |
Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Device Removal; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Tumor Burden; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2011 |
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Middle Aged; Multivariate Analysis; Premenstrual Syndrome; Surveys and Questionnaires; Treatment Outcome | 2012 |
Levonorgestrel-releasing intrauterine system versus laparoscopic supracervical hysterectomy for the treatment of heavy menstrual bleeding: a randomized study.
Topics: Adult; Body Mass Index; Female; Hemoglobins; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Outcome Assessment, Health Care; Pain, Postoperative; Parity; Pregnancy; Quality of Life; Rome; Surveys and Questionnaires | 2012 |
Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
Topics: Adult; Contraceptive Agents, Female; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia | 2012 |
Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Time Factors | 2013 |
Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Endometrial Ablation Techniques; Female; Follow-Up Studies; Hemoglobins; Humans; Hyperthermia, Induced; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Treatment Failure | 2013 |
Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
Topics: Adult; Antifibrinolytic Agents; Contraceptive Agents, Female; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Progestins; Quality of Life; Severity of Illness Index; Sexual Behavior; Tranexamic Acid | 2013 |
Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study.
Topics: Adult; Climacteric; Contraceptive Agents, Female; Drug Administration Schedule; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Pilot Projects; Progesterone Congeners | 2002 |
Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Topics: Adult; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Neoplasms; Uterus; Vagina | 2002 |
Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.
Topics: Abdominal Pain; Adult; Contraceptives, Postcoital; Double-Blind Method; Female; Headache; Humans; Levonorgestrel; Menorrhagia; Nausea; Nigeria; Placebos; Pregnancy; Safe Sex; Vomiting | 2002 |
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.
Topics: Adrenomedullin; Adult; Contraceptive Agents, Female; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Peptides; Time Factors; Vascular Endothelial Growth Factor A | 2003 |
Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia.
Topics: Biopsy; Catheterization; Endometrium; Female; Hot Temperature; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Uterus | 2003 |
Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia.
Topics: Adult; China; Estradiol; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Progesterone; Progesterone Congeners | 2003 |
A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menopause; Menorrhagia; Odds Ratio | 2004 |
Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.
Topics: Adult; Blood Volume; Contraceptive Agents, Female; Female; Follow-Up Studies; Health Status; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Predictive Value of Tests; Quality of Life; Treatment Outcome | 2004 |
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
Topics: Adult; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Quality of Life; Sickness Impact Profile | 2004 |
The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial.
Topics: Adult; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Prospective Studies; Treatment Outcome | 2005 |
Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Ferritins; Hemoglobins; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Time Factors | 2004 |
Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Mefenamic Acid; Menorrhagia; Menstruation; Middle Aged; Treatment Outcome | 2005 |
A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Topics: Adult; Aged; Catheter Ablation; Catheterization; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies; Quality of Life; Treatment Outcome | 2006 |
Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study.
Topics: Adult; Catheter Ablation; Catheterization; Contraceptive Agents, Female; Endometrium; Female; Follow-Up Studies; Health Status; Hemoglobins; Humans; Intrauterine Devices, Medicated; Iron Deficiencies; Levonorgestrel; Menorrhagia; Mental Health; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2006 |
Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Topics: Catheterization; Contraceptives, Oral, Synthetic; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2006 |
[Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Topics: Adult; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies; Treatment Outcome | 2006 |
The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
Topics: Adult; Contraceptives, Oral, Synthetic; Endometrium; Erythrocyte Indices; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Follow-Up Studies; Hematocrit; Hemostasis; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menorrhagia; Menstruation; Middle Aged; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Plasminogen Activators; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Thrombelastography; Time Factors; Treatment Outcome; von Willebrand Factor | 2007 |
Effect of hysterectomy or LNG-IUS on serum inhibin B levels and ovarian blood flow.
Topics: Adult; Arteries; Blood Flow Velocity; Female; Humans; Hysterectomy; Inhibins; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovary; Pulsatile Flow; Treatment Outcome; Ultrasonography | 2007 |
Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies; Treatment Outcome | 2007 |
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Multivariate Analysis; Patient Satisfaction; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Treatment Outcome | 2007 |
Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK.
Topics: Adult; Catheter Ablation; Cost-Benefit Analysis; Drug Costs; Endometrium; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; United Kingdom | 2007 |
A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Mifepristone; Ovary; Ultrasonography; Uterus | 2007 |
Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Topics: Adult; Catheter Ablation; Catheterization; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Treatment Outcome | 2007 |
Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers.
Topics: Administration, Oral; Adult; Anemia; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Perimenopause; Prospective Studies; Smoking; Treatment Outcome | 2008 |
Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
Topics: Adult; Anemia; China; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Time Factors | 1995 |
Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Topics: Adult; Endometrium; Female; Follow-Up Studies; Health Status Indicators; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Progesterone Congeners; Prospective Studies; Quality of Life; Recurrence; Time Factors | 1997 |
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Topics: Adult; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norethindrone; Patient Satisfaction; Progesterone Congeners; Treatment Outcome; Uterine Hemorrhage | 1998 |
Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia.
Topics: Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Patient Satisfaction; Progesterone Congeners; Randomized Controlled Trials as Topic | 1998 |
GyneFix-LNG: preliminary clinical experience with a copper and levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menorrhagia; Middle Aged; Sexually Transmitted Diseases | 1999 |
Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea.
Topics: Adult; Catheter Ablation; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Progesterone Congeners; Prospective Studies; Treatment Outcome | 2000 |
Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel.
Topics: Adult; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Ki-67 Antigen; Levonorgestrel; Menorrhagia; Middle Aged; Progesterone Congeners; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid | 2000 |
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.
Topics: Adult; Anxiety; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Depression; Female; Follow-Up Studies; Health Care Costs; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Mental Health; Middle Aged; Quality of Life; Sex | 2001 |
Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.
Topics: Adult; Climacteric; Dysmenorrhea; Endometrium; Female; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Menorrhagia | 2001 |
Clinical experience with Norplant subdermal implant system as long-term contraception during adolescence.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Greece; Humans; Hypertriglyceridemia; Levonorgestrel; Menorrhagia; Patient Acceptance of Health Care; Piroxicam; Psychology, Adolescent; Safety | 2002 |
Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
Topics: Adult; Amenorrhea; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Oligomenorrhea; Pilot Projects; Progesterone Congeners; Prospective Studies | 2002 |
A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia.
Topics: Adult; Catheter Ablation; Female; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Parity; Progesterone Congeners; Treatment Outcome; Uterus | 2002 |
192 other study(ies) available for levonorgestrel and Heavy Menstrual Bleeding
| Article | Year |
|---|---|
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Pregnancy | 2022 |
Comparison of Levonorgestrel-releasing Intrauterine System (LNG-IUS) against Laparoscopic Assisted Supracervical Hysterectomy (LASH) for menorrhagia treatment: An economic evaluation.
Topics: Cost-Benefit Analysis; Female; Humans; Hysterectomy; Intrauterine Devices; Laparoscopy; Levonorgestrel; Menorrhagia; Quality of Life; Quality-Adjusted Life Years; State Medicine | 2021 |
Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2022 |
Heavy Menstrual Bleeding in Adolescent: Normal or a Sign of an Underlying Disease?
Topics: Adolescent; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation; Menstruation Disturbances; Ovary | 2022 |
Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.
Topics: Adolescent; Adult; Child; Contraceptive Agents, Female; Ehlers-Danlos Syndrome; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Retrospective Studies; Young Adult | 2022 |
Caregiver Knowledge of and Attitudes Toward the Levonorgestrel-Containing Intrauterine Device for the Treatment of Heavy Menstrual Bleeding in Adolescents and Young Adults.
Topics: Adolescent; Adult; Attitude; Caregivers; Child; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Young Adult | 2022 |
Adenomyosis: Diagnosis and Management.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Endometriosis; Female; Humans; Hysterectomy; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Pelvic Pain; Pregnancy; Risk Factors; Ultrasonography | 2022 |
Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device study.
Topics: Adult; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Uterine Perforation | 2022 |
Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Young Adult | 2022 |
Levonorgestrel-Releasing Intrauterine Device Use Can Be a Treatment Option in Symptomatic Patients with Isthmocele.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Prospective Studies | 2022 |
Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI).
Topics: Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Japan; Levonorgestrel; Menorrhagia; Prospective Studies; Quality of Life | 2022 |
Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Japan; Levonorgestrel; Menorrhagia; Prospective Studies; Quality of Life | 2022 |
Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Topics: Adenomyosis; Cohort Studies; Contraceptive Agents; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage | 2022 |
Intrauterine Device Outcomes in Young Women with Heavy Menstrual Bleeding: Comparing Patients with and without Inherited Bleeding Disorders.
Topics: Adolescent; Adult; Child; Cohort Studies; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Young Adult | 2022 |
Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Topics: Adenomyosis; Chronic Pain; Dysmenorrhea; Female; Follow-Up Studies; Humans; Japan; Levonorgestrel; Menorrhagia; Pelvic Pain; Prospective Studies | 2022 |
Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2023 |
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Pregnancy | 2022 |
Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern.
Topics: Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Prospective Studies | 2023 |
Medical treatment for heavy menstrual bleeding in primary care: 10-year data from the ECLIPSE trial.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Menorrhagia; Primary Health Care; Prospective Studies; Quality of Life | 2022 |
Levonorgestrel intrauterine devices improve body constitution deviations in the perspective of traditional Chinese medicine and quality of life in patients with chronic pelvic pain and heavy menstrual bleeding.
Topics: Body Constitution; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medicine, Chinese Traditional; Menorrhagia; Pelvic Pain; Quality of Life | 2022 |
THE ANALYSIS OF THE IMPACT OF THE TYPE OF CONTRACEPTION USED BY WOMEN ON THE LEVEL OF THEIR SEXUAL SATISFACTION AND COMFORT OF USE.
Topics: Contraception; Female; Humans; Levonorgestrel; Menorrhagia; Orgasm | 2022 |
Sensitivity to Change of the SAMANTA Questionnaire, a Heavy Menstrual Bleeding Diagnostic Tool, After 1 Year of Hormonal Treatment.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Menorrhagia; Menstruation; Quality of Life; Surveys and Questionnaires | 2023 |
Practice variation in the stepped care approach to idiopathic heavy menstrual bleeding: A population-based study.
Topics: Cross-Sectional Studies; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2023 |
Treatment of abnormal uterine bleeding using levonorgestrel-releasing intrauterine devices: experience from a Turkish tertiary hospital.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Tertiary Care Centers | 2023 |
Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report.
Topics: Adolescent; Contraceptive Agents, Female; Ehlers-Danlos Syndrome; Ehlers-Danlos Syndrome, Type IV; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Treatment Outcome | 2023 |
Intrauterine devices for menorrhagia.
Topics: Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2023 |
Is chronic pelvic pain or heavy menstrual bleeding the main target beneficial to the use of levonorgestrel intrauterine devices?
Topics: Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Pain; Progesterone | 2023 |
Women's experiences of heavy menstrual bleeding and medical treatment: a qualitative study in primary care.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Primary Health Care; Progesterone; Qualitative Research | 2023 |
Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri.
Topics: Cross-Sectional Studies; Female; Humans; Hysterectomy; Laparoscopy; Levonorgestrel; Menorrhagia; Uterus | 2023 |
Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
Topics: Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Uterine Perforation | 2023 |
Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.
Topics: Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic | 2023 |
Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders; Contraceptive Agents; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2019 |
Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders; Contraceptive Agents; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2019 |
Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Young Adult | 2020 |
Gynecologic Management of Pediatric and Adolescent Patients with Ehlers-Danlos Syndrome.
Topics: Adolescent; Contraceptive Agents, Hormonal; Dysmenorrhea; Ehlers-Danlos Syndrome; Female; Gynecology; Humans; Levonorgestrel; Menorrhagia; Pregnancy; Referral and Consultation; Retrospective Studies | 2020 |
Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study.
Topics: Adolescent; Adult; Denmark; Drug Utilization; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Middle Aged; Progestins; Tranexamic Acid; Young Adult | 2020 |
Bleeding Patterns among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review.
Topics: Adolescent; Adult; Amenorrhea; Child; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Menorrhagia; Menstruation; Retrospective Studies; Young Adult | 2020 |
Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Topics: Adult; Blood Coagulation Disorders, Inherited; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Uterine Hemorrhage | 2020 |
Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Feasibility Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Pain Management; Retrospective Studies; Time Factors; Uterus | 2020 |
Vascular effect of levonorgestrel intrauterine system on heavy menstrual bleeding: is it associated with hemodynamic changes in uterine, radial, and spiral arteries?
Topics: Adult; Contraceptive Agents, Female; Female; Hemodynamics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menorrhagia; Middle Aged; Myometrium; Prospective Studies; Radial Artery; Uterine Artery | 2021 |
Combined transcervical endometrial resection and levonorgestrel device treatment compared to transcervical endometrial resection for abnormal uterine bleed.
Topics: Cohort Studies; Combined Modality Therapy; Contraceptive Agents, Hormonal; Denmark; Endometrial Ablation Techniques; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Progesterone; Progesterone Congeners; Retrospective Studies; Treatment Outcome | 2020 |
Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
Topics: Adult; Amenorrhea; Anticoagulants; Blood Coagulation Disorders; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Retrospective Studies; Thromboembolism; Thrombosis | 2020 |
Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
Topics: Adenomyosis; Feasibility Studies; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Menorrhagia | 2021 |
Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding.
Topics: Adolescent; Adult; Attitude of Health Personnel; Blood Coagulation Disorders; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Practice Patterns, Physicians'; Surveys and Questionnaires | 2021 |
Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
Topics: Cesarean Section; Child; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Netherlands; Pregnancy | 2021 |
The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Topics: Adenomyosis; Adult; Cohort Studies; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Ultrasonography | 2021 |
The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey.
Topics: Adolescent; Adult; Contraceptives, Oral; Delayed Diagnosis; Female; Health Services Accessibility; Health Surveys; Hormonal Contraception; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2021 |
The levonorgestrel intrauterine system versus endometrial ablation: when the choice of treatment goes beyond its efficacy.
Topics: Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2021 |
Management of heavy menstrual bleeding in Australian general practice: An analysis of BEACH data.
Topics: Australia; Female; General Practice; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2021 |
Levonorgestrel-Releasing Intrauterine System for Reducing Heavy Menstrual Bleeding.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2021 |
Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study.
Topics: Contraceptive Agents, Female; Endometrial Ablation Techniques; Female; Humans; Levonorgestrel; Menorrhagia; Treatment Outcome; von Willebrand Factor | 2021 |
Comparative effectiveness and impact on health-related quality of life of hysterectomy vs. levonorgestrel intra-uterine system for abnormal uterine bleeding.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Retrospective Studies | 2017 |
Incidence and treatment of heavy menstrual bleeding in general practice.
Topics: Adult; Female; General Practice; Guidelines as Topic; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Netherlands; Practice Patterns, Physicians'; Registries; Retrospective Studies | 2017 |
Intrauterine device visualized as extrinsic bladder mass on cystoscopy.
Topics: Contraceptive Agents, Female; Cystoscopy; Device Removal; Female; Foreign Bodies; Humans; Intrauterine Device Migration; Intrauterine Devices, Medicated; Levonorgestrel; Lower Urinary Tract Symptoms; Menorrhagia; Middle Aged; Ultrasonography; Urinary Bladder; Urinary Bladder Diseases | 2017 |
Evaluation of quality of life and cost-effectiveness of definitive surgery and the levonorgestrel intrauterine system as treatment options for heavy menstrual bleeding.
Topics: Adult; Cost-Benefit Analysis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Postoperative Complications; Quality of Life; Treatment Outcome; Young Adult | 2017 |
Cost-effectiveness of treatments for heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Decision Trees; Endometrial Ablation Techniques; Female; Health Care Costs; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Quality-Adjusted Life Years | 2017 |
Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Mitotane | 2017 |
Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Prospective Studies; Treatment Outcome; Turkey | 2018 |
Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: A survey-based study.
Topics: Acne Vulgaris; Alopecia; Female; Hirsutism; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Surveys and Questionnaires | 2018 |
Menorrhagia Outcomes of Minimally Invasive Treatments (MOMITS): A 2 to 5-year follow-up.
Topics: Catheter Ablation; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Retrospective Studies; Symptom Assessment; Time Factors; Treatment Outcome | 2017 |
Heavy menstrual bleeding: a global survey of health care practitioners' perceptions.
Topics: Adult; Attitude of Health Personnel; Contraception Behavior; Contraceptives, Oral; Female; Global Health; Health Personnel; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Needs Assessment; Patient Compliance; Surveys and Questionnaires | 2018 |
Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Topics: Adult; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Preference | 2018 |
[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts; Ovarian Neoplasms; Pregnancy | 2018 |
Case Report of the Successful Use of Mirena Levonorgestrel Intrauterine System in a Patient with Didelphys Uterus and Obstructed Hemivagina.
Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Menstruation; Ultrasonography; Urogenital Abnormalities; Uterus; Vaginal Diseases | 2019 |
Treatment of menorrhagia due to aplastic anemia by hysteroscopic resection of endometrial functional layer and levonorgestrel-releasing intra-uterine system: Three case reports.
Topics: Adult; Anemia, Aplastic; Contraceptive Agents, Female; Endometrial Ablation Techniques; Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia | 2019 |
Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type III von Willebrand disease.
Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; von Willebrand Diseases | 2013 |
The levonorgestrel intrauterine system: effective non-surgical treatment for heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2013 |
Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Contraceptive Agents, Female; Female; Ferritins; Hemoglobins; Humans; Levonorgestrel; Menorrhagia; Menstruation; Patient Satisfaction; Retrospective Studies; Young Adult | 2013 |
Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding.
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Treatment Outcome | 2013 |
Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report.
Topics: Acute Disease; Adenomyosis; Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menorrhagia; Urticaria | 2014 |
Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Depression; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Surveys and Questionnaires; Young Adult | 2014 |
Long-term consequences of LNG-IUS vs. hysterectomy for menorrhagia.
Topics: Female; Health Care Costs; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Quality of Life | 2014 |
Are two intrauterine contraceptive devices better than one?
Topics: Contraceptive Agents, Female; Diagnostic Errors; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ultrasonography; Uterine Neoplasms; Uterus | 2014 |
Different bleeding patterns with the use of levonorgestrel intrauterine system: are they associated with changes in uterine artery blood flow?
Topics: Adolescent; Adult; Blood Flow Velocity; Endometrium; Female; Hemorrhage; Humans; Intrauterine Devices; Levonorgestrel; Longitudinal Studies; Menorrhagia; Menstruation; Middle Aged; Ultrasonography, Doppler; Uterine Artery; Uterus; Young Adult | 2014 |
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Finland; Follow-Up Studies; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Lung Neoplasms; Menorrhagia; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Registries | 2014 |
[Use of progesterone-releasing intra-uterine system in menhorragia relapse prevention after laparoscopic myomectomy].
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Laparoscopy; Leiomyoma; Levonorgestrel; Menorrhagia; Pelvic Pain; Quality of Life; Retrospective Studies; Secondary Prevention; Time Factors; Uterine Myomectomy | 2014 |
Managing menorrhagia in a familial case of factor V deficiency.
Topics: Adolescent; Aminocaproic Acid; Antifibrinolytic Agents; Child; Contraceptive Agents, Female; Factor V Deficiency; Female; Humans; Levonorgestrel; Menorrhagia; Siblings | 2015 |
Long acting reversible contraception in adolescents with cardiovascular conditions.
Topics: Adolescent; Cardiovascular Diseases; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Young Adult | 2014 |
Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Combinations; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Models, Theoretical; Nandrolone; Spain | 2015 |
Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Menorrhagia; Outcome Assessment, Health Care; Quality of Life; Surveys and Questionnaires; United Kingdom; Women's Health Services | 2015 |
Abnormal uterine bleeding: Taking the stress out of controlling the flow.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Hormone Replacement Therapy; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Perimenopause; Progestins | 2015 |
Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Cohort Studies; Device Removal; Dysmenorrhea; Female; Follow-Up Studies; Gestational Age; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pregnancy; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Ultrasonography | 2015 |
Endometrial Synovial-like Metaplasia Associated With Levonorgestrel-releasing Intrauterine System.
Topics: Adult; Biomarkers; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Foreign-Body Reaction; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Metaplasia; Middle Aged; Synovial Membrane | 2015 |
One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies; Quality of Life; Spain; Surveys and Questionnaires | 2016 |
Levonorgestrel-Releasing Intrauterine Device Use in Female Adolescents with Heavy Menstrual Bleeding and Bleeding Disorders: Single Institution Review.
Topics: Adolescent; Child; Contraceptive Agents, Female; Female; Hemorrhagic Disorders; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies | 2017 |
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Fallopian Tube Neoplasms; Female; Finland; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Neoplasms; Risk Factors | 2016 |
[A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Prospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2016 |
Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
Topics: Abortion, Induced; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; United States; Young Adult | 2016 |
The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Obesity; Prospective Studies; Quality of Life; Surveys and Questionnaires; Visual Analog Scale | 2016 |
Re: Choice of primary outcomes evaluating treatment for heavy menstrual bleeding.
Topics: Choice Behavior; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2017 |
Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO.
Topics: Adult; Cohort Studies; Family Planning Services; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Progesterone; Retrospective Studies | 2008 |
Menorrhagia and severe menstrual pain related to the use of adalimumab in a psoriatic.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Contraceptives, Oral, Combined; Drug Combinations; Drug Labeling; Dysmenorrhea; Etanercept; Ethinyl Estradiol; Female; Humans; Immunoglobulin G; Immunologic Factors; Levonorgestrel; Menorrhagia; Obesity, Morbid; Product Surveillance, Postmarketing; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; United Kingdom; United States | 2008 |
The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
Topics: Adult; Contraceptive Agents, Female; Female; Ferritins; Follow-Up Studies; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Prospective Studies; Quality of Life; Sickness Impact Profile; Spain | 2008 |
Two for the price of one.
Topics: Adult; Anemia; Anti-HIV Agents; Contraceptive Agents, Female; Drug Therapy, Combination; Endometriosis; Female; HIV Seropositivity; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
[Menorrhagy].
Topics: Adolescent; Adult; Age Factors; Embolization, Therapeutic; Female; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Progestins; Uterine Neoplasms | 2008 |
Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Topics: Adult; Contraceptives, Oral, Synthetic; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Luteinizing Hormone; Menorrhagia; Middle Aged; Ovary; Regression Analysis; Uterine Neoplasms; Uterus | 2009 |
Mirena coil for heavy menstrual bleeding.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Patient Satisfaction | 2008 |
Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Prospective Studies; Young Adult | 2009 |
[Medical treatment of idiopathic menorrhagia].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Estrogens; Female; Humans; Levonorgestrel; Menorrhagia; Progestins; Uterine Hemorrhage; Uterus | 2008 |
Abnormal uterine bleeding: avoid the rush to hysterectomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptive Agents, Female; Danazol; Diagnosis, Differential; Drug Therapy, Combination; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Metrorrhagia; Minimally Invasive Surgical Procedures; Practice Guidelines as Topic; Pregnancy Tests; Progestins; Treatment Outcome; Uterine Hemorrhage | 2009 |
The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstrual Cycle; Middle Aged; Patient Satisfaction; Patient Selection; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2009 |
Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Topics: Adult; Age Factors; Delayed-Action Preparations; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Treatment Outcome; Uterine Neoplasms; Uterus; Young Adult | 2010 |
Levonorgestrel-IUD should be offered before hysterectomy for abnormal uterine bleeding without uterine structural abnormalities: there are no more excuses!
Topics: Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2009 |
The hormone-releasing intrauterine device has benefits over hysterectomy for many women. Press release.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pain | 2009 |
Translational research in women's health: from bedside to bench and from bench to bedside.
Topics: Apoptosis; Clinical Trials as Topic; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Menorrhagia; Norpregnadienes; Proliferating Cell Nuclear Antigen; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms; Women's Health | 2010 |
Contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Monitoring; Female; Humans; Levonorgestrel; Menorrhagia; Obesity; Pelvic Pain | 2010 |
Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome | 2010 |
Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents.
Topics: Adolescent; Contraceptive Agents, Female; Drug Resistance; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intellectual Disability; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Treatment Outcome | 2010 |
Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
Topics: Adult; Anemia; Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Uterine Diseases | 2010 |
Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device?
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menorrhagia; Middle Aged; Patient Satisfaction; Retrospective Studies | 2011 |
Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Topics: Adolescent; Adult; Amenorrhea; Canada; Clinical Trials, Phase III as Topic; Contraceptives, Oral, Combined; Dosage Forms; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menorrhagia; Metrorrhagia; Middle Aged; Multicenter Studies as Topic; Patient Satisfaction; Young Adult | 2010 |
Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Progestins | 2010 |
Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Hemorrhagic Disorders; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Surveys and Questionnaires; Young Adult | 2011 |
Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Treatment Outcome; Uterine Hemorrhage | 2011 |
The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
Topics: Dysmenorrhea; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Perimenopause; Retrospective Studies; Risk Factors; Severity of Illness Index | 2012 |
Clinical outcome of levonorgestrel intra-uterine system in idiopathic menorrhagia.
Topics: Administration, Intravaginal; Adult; Biomarkers; Chi-Square Distribution; Contraceptive Agents, Female; Developing Countries; Female; Hemoglobins; Humans; India; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Patient Satisfaction; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Psychometrics; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome | 2011 |
Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2012 |
Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
Topics: Adult; Biopsy; Combined Modality Therapy; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Treatment Outcome | 2012 |
Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.
Topics: Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Immunocompromised Host; Intrauterine Devices, Medicated; Kidney Transplantation; Levonorgestrel; Menorrhagia; Middle Aged; Pelvic Infection; Retrospective Studies | 2012 |
Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
Topics: Adult; Brazil; Cohort Studies; Contraceptive Agents, Female; Female; Health Resources; Humans; Hysterectomy; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Postoperative Complications | 2012 |
An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia.
Topics: Adult; Combined Modality Therapy; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Patient Satisfaction; Surveys and Questionnaires; Treatment Outcome | 2012 |
Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged | 2012 |
Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Uterine Neoplasms | 2012 |
Levonorgestrel intrauterine system--first-line therapy for heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2013 |
Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludes.
Topics: Contraceptive Agents, Female; Female; General Practice; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Treatment Outcome | 2013 |
Levonorgestrel intrauterine system works best for heavy periods.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Treatment Outcome | 2013 |
Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Asia; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Progestins; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Topics: Adult; Blood Vessels; Contraceptive Agents, Female; Drug Implants; Endometrium; Epithelium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Prospective Studies; Uterine Hemorrhage | 2002 |
The levonorgestrel intrauterine system: a simple and effective alternative for the management of menorrhagia?
Topics: Adult; Double-Blind Method; Female; Finland; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Premenopause; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Endometrial adenocarcinoma following the insertion of a Mirena IUCD.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged | 2002 |
The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone Congeners | 2003 |
The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Neoplasms | 2003 |
Update on treatment of menstrual disorders.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Embolization, Therapeutic; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Uterine Neoplasms | 2003 |
Studies evaluate hysterectomy as treatment for abnormal uterine bleeding.
Topics: Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Patient Satisfaction; Quality of Life | 2004 |
Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
Topics: Female; Ferritins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Ultrasonography | 2004 |
I want my Mirena out!
Topics: Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Audit; Menorrhagia; Pregnancy; Risk Assessment; South Africa; Uterine Hemorrhage | 2004 |
Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey.
Topics: Adult; Attitude of Health Personnel; Contraceptive Agents, Female; Female; Gynecology; Humans; Intrauterine Devices, Copper; Israel; Levonorgestrel; Menorrhagia; Middle Aged; Practice Patterns, Physicians'; Surveys and Questionnaires | 2004 |
The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
Topics: Adolescent; Adult; Blood Coagulation Disorders, Inherited; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Prospective Studies | 2004 |
Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns.
Topics: Amenorrhea; Biomarkers; Biopsy; Contraceptives, Oral, Synthetic; Endometrium; Estradiol; Female; Humans; Interleukin-13; Interleukin-15; Levonorgestrel; Menorrhagia; Menstruation; Patient Compliance; Progesterone; Surveys and Questionnaires | 2005 |
von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system.
Topics: Adult; Contraception; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Risk Assessment; Treatment Outcome; von Willebrand Diseases | 2005 |
Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Topics: Adult; Belgium; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged | 2005 |
Experience with shared decision making in gynaecological practice: treatment decisions in patients with dysfunctional uterine blood loss.
Topics: Adult; Decision Support Techniques; Endometrium; Female; Health Care Costs; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2005 |
An evaluation of troublesome inter-menstrual bleeding in menorrhagic users of the LNG-IUS.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Uterine Hemorrhage; Uterus | 2005 |
Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Intrauterine Devices, Medicated; Lateral Sinus Thrombosis; Levonorgestrel; Menorrhagia | 2005 |
The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2005 |
The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.
Topics: Female; Hemostatic Disorders; Humans; Levonorgestrel; Menorrhagia; Retrospective Studies | 2005 |
Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Topics: Adult; Anemia; Blood Flow Velocity; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Myoma; Time Factors; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2005 |
The management of endometrial hyperplasia: an evaluation of current practice.
Topics: Aged; Aged, 80 and over; Biopsy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage | 2006 |
Re: The use of levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders.
Topics: Adult; Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Randomized Controlled Trials as Topic | 2006 |
The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
Topics: Adult; Arteries; Blood Flow Velocity; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pulsatile Flow; Uterine Hemorrhage; Uterus; Vascular Resistance | 2006 |
A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia.
Topics: Adult; Cost-Benefit Analysis; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Markov Chains; Menorrhagia; Quality-Adjusted Life Years | 2006 |
Effects of levonorgestrel-releasing intrauterine system on glucose and lipid metabolism: a 1-year follow-up study.
Topics: Adult; Blood Glucose; Blood Pressure; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipid Metabolism; Menorrhagia; Middle Aged; Prospective Studies | 2006 |
ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Intrauterine Devices; Levonorgestrel; Menorrhagia; Selective Estrogen Receptor Modulators; Tamoxifen | 2006 |
Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menorrhagia; Menstruation; Middle Aged; Pelvic Inflammatory Disease; Safety; Treatment Outcome; Virus Shedding | 2007 |
Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil).
Topics: Administration, Oral; Adult; Anticoagulants; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Thrombosis; Treatment Outcome; Warfarin | 2006 |
Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Oligomenorrhea; Prospective Studies; Time Factors; Treatment Outcome; Uterine Neoplasms; Uterus | 2007 |
Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
Topics: Adult; Contraceptive Agents, Female; Female; Health Care Costs; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Managed Care Programs; Menorrhagia; Middle Aged; Patient Satisfaction; Quality of Life; Treatment Outcome; United States | 2007 |
An important Finnish contribution to the advancement of women's reproductive health.
Topics: Female; Humans; Levonorgestrel; Menorrhagia; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Women's Health | 2007 |
Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstrual Cycle; Oligomenorrhea; Patient Satisfaction; Treatment Outcome | 2007 |
Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Depression; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medical Futility; Menorrhagia; Prospective Studies; Uterus | 2007 |
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Topics: Endometrial Hyperplasia; Endometriosis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Retrospective Studies; Treatment Failure; Uterine Neoplasms; Uterus | 2008 |
Shifting indications for hysterectomy.
Topics: Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 1995 |
Hormonal intrauterine devices.
Topics: Adolescent; Adult; Amenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Inflammatory Disease; Pregnancy; Sweden; Uterine Hemorrhage | 1993 |
Risk factors for discontinuation of Norplant implant use due to menstrual problems.
Topics: Adult; Body Weight; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Pregnancy; Risk Factors; Smoking | 1996 |
The levonorgestrel intrauterine system in the management of menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Patient Participation; Prospective Studies | 1997 |
Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Topics: Adult; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies | 1997 |
Endothelin receptor expression in human decidua.
Topics: Abortion, Induced; Biopsy; Collagen; Decidua; Female; Humans; Laminin; Levonorgestrel; Ligands; Menorrhagia; Norethindrone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Progesterone Congeners; Receptors, Endothelin | 1998 |
Is medical management of menorrhagia obsolete?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Estrogen Replacement Therapy; Female; Humans; Hysteroscopy; Laparoscopy; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid | 1998 |
Editor's Choice: menorrhagia and endometrial ablation.
Topics: Catheter Ablation; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone Congeners | 1998 |
Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Ecchymosis; Endometrial Neoplasms; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Polyps; Purpura; Sensitivity and Specificity; Uterus | 1998 |
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Patient Satisfaction; Progesterone Congeners; Randomized Controlled Trials as Topic | 1999 |
Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in a woman on hemodialysis.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Progesterone Congeners; Renal Dialysis | 1999 |
Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Topics: Adult; Blood Transfusion; Contraceptive Agents, Female; Dysmenorrhea; Female; Hematinics; Hemoglobins; Humans; Intrauterine Devices, Medicated; Kidney Transplantation; Leiomyoma; Levonorgestrel; Menorrhagia; Ovary; Ultrasonography; Uterine Neoplasms; Uterus | 1999 |
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraindications; Drug Implants; Endometriosis; Female; Humans; Hysterectomy; Levonorgestrel; Malignant Hyperthermia; Menorrhagia; Progesterone Congeners; Uterine Hemorrhage; Uterus | 1999 |
Modern approaches to management of menorrhagia.
Topics: Adult; Endometrium; Female; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Education as Topic; Pregnancy; Randomized Controlled Trials as Topic | 2000 |
Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
Topics: Adult; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Plasminogen Activator Inhibitor 1; RNA, Messenger | 2000 |
Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Menstruation; Ovulation; Prospective Studies; Uterine Hemorrhage; Vascular Diseases | 2000 |
Management of menorrhagia--SMART study (Satisfaction with Mirena and Ablation: a Randomised Trial).
Topics: Endometrium; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Patient Satisfaction; Treatment Outcome | 2000 |
[Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids].
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Administration Routes; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2000 |
Treatment of menorrhagia.
Topics: Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Randomized Controlled Trials as Topic | 2001 |
The management of menorrhagia--SMART study (Satisfaction with Mirena and Ablation: a Randomised Trial).
Topics: Catheter Ablation; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adult; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 2001 |
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium.
Topics: Adult; Apoptosis; Cell Division; Drug Delivery Systems; Endometriosis; Endometrium; fas Receptor; Female; Humans; Levonorgestrel; Menorrhagia; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Time Factors | 2001 |
Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia?
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Patient Satisfaction; Progesterone Congeners; Treatment Outcome | 2002 |
The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adult; Drug Delivery Systems; Drug Implants; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 2002 |
A retrospective cohort study comparing microwave endometrial ablation with levonorgestrel-releasing intrauterine device in the management of heavy menstrual bleeding.
Topics: Adult; Chi-Square Distribution; Cohort Studies; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Microwaves; Middle Aged; Patient Satisfaction; Probability; Progesterone Congeners; Quality of Life; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; South Australia; Statistics, Nonparametric; Treatment Outcome | 2002 |
[Intrauterine device-induced menorrhagia and endometrial content of prostacyclins].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Endometrium; Epoprostenol; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Thromboxane B2 | 1992 |
Quantitation of hormone replacement induced withdrawal bleeds.
Topics: Adult; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Norgestrel | 1991 |
A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Topics: Adult; Female; Flurbiprofen; Hemoglobins; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norgestrel; Tranexamic Acid | 1991 |
Management of menorrhagia.
Topics: Contraceptive Agents, Female; Costs and Cost Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norgestrel; United Kingdom | 1990 |
Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
Topics: Adult; Consumer Behavior; Contraceptive Agents, Female; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norgestrel; Prognosis; Quality of Life; Time Factors | 1990 |